Clinical Trials
4
Active:0
Completed:0
Trial Phases
2 Phases
Phase 1:1
Phase 2:3
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
Phase 2
3 (75.0%)Phase 1
1 (25.0%)Sorafenib, Bevacizumab, and Oxaliplatin in Treating Patients With Metastatic Malignant Melanoma
Phase 1
- Conditions
- Melanoma (Skin)
- First Posted Date
- 2007-10-02
- Last Posted Date
- 2014-01-10
- Target Recruit Count
- 54
- Registration Number
- NCT00538005
- Locations
- 🇺🇸
San Diego Pacific Oncology and Hematology Associates, Incorporated - Encinitas, Encinitas, California, United States
Radiation Therapy, Temozolomide, Tamoxifen, and Carboplatin in Treating Patients With Malignant Gliomas
Phase 2
- Conditions
- Brain and Central Nervous System Tumors
- First Posted Date
- 2007-06-27
- Last Posted Date
- 2014-01-10
- Target Recruit Count
- 80
- Registration Number
- NCT00492687
- Locations
- 🇺🇸
San Diego Pacific Oncology and Hematology Associates, Incorporated - Encinitas, Encinitas, California, United States
Sorafenib, Tamoxifen, and Cisplatin in Treating Patients With High-Risk Stage III Melanoma
Phase 2
- Conditions
- Melanoma (Skin)
- First Posted Date
- 2007-06-27
- Last Posted Date
- 2014-01-10
- Target Recruit Count
- 200
- Registration Number
- NCT00492505
- Locations
- 🇺🇸
San Diego Pacific Oncology and Hematology Associates, Incorporated - Encinitas, Encinitas, California, United States
Sunitinib, Tamoxifen, and Cisplatin in Treating Patients With High-Risk Ocular Melanoma
Phase 2
- Conditions
- Intraocular Melanoma
- First Posted Date
- 2007-06-21
- Last Posted Date
- 2014-01-10
- Target Recruit Count
- 50
- Registration Number
- NCT00489944
- Locations
- 🇺🇸
San Diego Pacific Oncology and Hematology Associates, Incorporated - Encinitas, Encinitas, California, United States
News
No news found